Cencora (COR) said Wednesday in a regulatory filing that certain Walgreens volume that was being serviced by the company, separate from the prime vendor agreement, has started moving outside the company from July 1.
Meanwhile, Cencora said its prime vendor agreement remains unchanged and accounts for the majority of its business with Walgreens.
Cencora reaffirmed its fiscal year 2026 adjusted diluted EPS guidance range of $17.75 to $17.95.
Analysts polled by FactSet expect $17.86.
Shares of the company were down 4.4% in Wednesday trading.
Price: 319.45, Change: -14.42, Percent Change: -4.32
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments